CatalystEU/UK

Eli Lilly raises earnings outlook as obesity drug demand drives strong growth, UBS says - Yahoo Finance

Eli Lilly raised earnings outlook on strong obesity drug demand, per UBS.

What changed

Eli Lilly raised earnings outlook on strong obesity drug demand, per UBS.

Why it matters

Eli Lilly raised earnings outlook on strong obesity drug demand, per UBS. — impact context not separately stored; see What changed.

Sources